118
Views
5
CrossRef citations to date
0
Altmetric
Articles

t(8;21) (q22;q22) Acute myelogenous leukemia in México: A single institution experience

, , , , , & show all
Pages 235-238 | Published online: 04 Sep 2013

References

  • Peterson LF, Zhang DE. The 8;21 translocation in leukemo-genesis. Oncogene 2004;23(24):4255–4262.
  • Ruiz-Arguelles GJ, McArthur J. Leucemias agudas. In: Ruiz-Arguelles GJ, editor. Editorial Médica Panamericana. 3rd ed. Mexico City: 2003. p 180–197.
  • Visani G, Isidori A, Grafone T, Tosi P, Santini V, Malagola M, Martinelli G, Piccaluga PP, Gaziev D, Ottaviani E, Sparaventi G, Tura S. No preferential sensitivity of t(8;21) acute myeloid leukemias to cytosine arabinoside in vitro: Is intensity of therapy or high dose Ara-C crucial for response? Leukemia Lymphoma 2004;45: 1361–1364.
  • Lai YY, Qiu JY, Jiang B, Lu XJ, Huang XJ, Liu YR, Shi Y, Dang H, He Q, Lu DP. Analysis of characteristics of 72 cases of t(8;21) acute myeloid leukemia. Beijing Da Xue Xue Bao 2005;37:245–248.
  • Ruiz-Arguelles A. Flow cytometry in the clinical laboratory. Principles, applications and problems. Ann Biol Clin 1992;50:735–743.
  • San-Miguel JF, Duque R. Utilidad del inmunofenotipo en el diagnOstico y clasificación de las leucemias agudas. In: Ruiz-Arguelles GJ, San-Miguel JF, editors. Editorial Médica Panamericana. Actualización en leucemias 1996. p 25–34.
  • Kozu T, Miyoshi H, Shimizu K, Maseki N, Kaneko Y, Asou H, Kamada N, Ohki M. Junctions of the ANIL1 / MTG8 (ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction. Blood 1993;82:1270–1276.
  • Ruiz-Arguelles GJ, Garcés-Eisele J, Reyes-NUfiez V, Perez-Romano B, Ruiz-Arguelles A, Ramirez-Cisneros F, López-Martinez B, LOpez-Tapia JD, Rivadeneyra-Espinoza L. Assessment of residual disease in acute leukemia by means of polymerase chain reaction: A prospective study in a single institution. Rev Invest Clin Méx 2000;52:118–124.
  • Ruiz-Arguelles GJ, Apreza-Molina MG, Aleman-Hoey DD, Gomez-Almaguer D, Marin-Lopez A, Mercado-Diaz L. Outpatient supportive therapy after induction to remission therapy in adult acute myelogenous leukaemia (AML) is feasible: A multicentre study. Eur J Haematol 1995;54:18–20.
  • Ruiz-Argiielles GJ, GOmez-Rangel D, Ruiz-Delgado GJ, Ruiz-Arguelles A, Pérez-Romano B, Rivadeneyra L. Results of an autologous non-cryopreserved, unmanipulated peripheral blood hematopoietic stem cell transplant program: A single institution, 10-year experience. Acta Haematologica 2003;110: 179–183.
  • Ruiz-Arguelles GJ, Gömez-Almaguer D, Gömez Rangel JD, Vela-Ojeda J, Cantu-Rodriguez OG, Jaime-Pérez JC, Gonza-lez-Llano O, Herrera-Garza JL. Allogeneic hematopoietic stem cell transplantation with non-myeloablative conditioning in patients with acute leukemia eligible for conventional allografting: A prospective study. Leukemia Lymphoma 2004;45: 1191–1195.
  • Ruiz-Arguelles A, Duque RE, Orfao A. Report on the first Latin American consensus conference for flow cytometric immunophenotyping of leukemia. Cytometry (Commun Clin Cytometry) 1998;34:39–42.
  • Ruiz-Arguelles A, Rivadeneyra-Espinoza L, Duque RE, Orfao A. Report of the second Latin American consensus conference for flow cytometric immunophenotyping of hematological malignancies. Cytometry (Commun Clin Cytometry) 2005;70B:39–44.
  • Kaplan EL, Meier P. Nonparametric estimations from incomplete observations. J Am Stat Assoc 1958;53:457–463.
  • Stone RNI, Donell MR, Sekers MA. Acute myeloid leukemia. In:Broudy VC, Berliner N, Larson RA, Leung LL, editors. American Society of Hematology. Hematology 2004. American Society of Hematology Education Program Book. USA: Washington DC: 2004. p 98–117.
  • Ruiz-Arguelles GJ. Promyelocytic leukemia in Mexican mestizos. Blood 1997;89:348–349.
  • Almaguer-Gaona C, Cantu-Rodriguez OG, Hernandez-Garza NE, Gomez-Almaguer D. Leucemia aguda. Observaciones epidemiológicas en el Hospital Universitario de la Universidad Autonoma de Nuevo Leon. Medicina Univ 1998;1:1517.
  • Ruiz-Arguelles GJ, Gomez-Almaguer D, Delgado-Lamas JL, Gil-Rondero C, Almaguer-Gaona C, Apreza-Molina MG. High frequency of acute promyelocytic leukemia in Mexican mestizos. A multicenter study. Blood 1997;90\(Suppl 1):233b, (Abstract).
  • Piedras J, LOpez-Karpovitch X, Cardenas MR. Cellular immunophenotypes in 97 adults with acute leukemia. Rev Invest Clin Méx 1997;49: 457–464.
  • Ruiz-Argiielles GJ, Morales-Toquero A, GOmez-Rangel JD, LOpez-Martinez B, Ruiz-Delgado GJ, Reyes-NUfiez V. Treat-ment of acute promyelocytic leukemia: A single institution experience. Rev Invest Clin Méx 2005;57:415–419.
  • Nucifora G, Rowley JD. ANIL1 and the 8:21 translocation in acute and chronic myeloid leukemia. Blood 1995;86:1–14.
  • Kita K, Nakase K, Miwa H. Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21) (q22;q22) chromosomal abnormality: Frequent expression of immature B cell antigen CD19 together with stem cell antigen CD34. Blood 1992;80: 470–477.
  • Marcucci G, Mrozek K, Ruppert AS, Maharry K, Kolitz JE, Moore JO, Mayer RJ, Pettenati MJ, Powell BL, Edwards CG, Sterling LJ, Vardiman JW, Schiffer CA, Carroll AJ, Larson RA, Bloomfield CD. Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): A Cancer and Leukemia Group B Study. J Clin Oncol 2005;23:5705–5717.
  • Swansbury GJ, Lawler SD, Alimena G. Long-term survival in acute myelogenous leukemia. A second follow up of the fourth international workshop on chromosomes in leukemia. Cancer Genet Cytogenet 1994;73:1–7.
  • Lobato-Mendizabal E, Ruiz-Arguelles GJ, Ganci-Cerrud G, Gomez-Almaguer D, Lozano-de-la-Vega A, Labardini-Mendez J. Tratamiento a largo plazo y factores pronOsticos en leucemia aguda mieloblastica del adulto. Experiencia del grupo INNSZ (Puebla-Monterrey-México). Rev Invest Clin Méx 1991;43: 215–222.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.